All Pharma News
Lynk Announced First Rheumatoid Arthritis Patient Dosed in PIII of LNK01001

Lynk Announced First Rheumatoid Arthritis Patient Dosed in PIII of LNK01001
PR NEWSWIRE
20 Dec 2023
Share Share
Lynk Pharmaceuticals Completes Series C2 Financing Round

Lynk Pharmaceuticals Completes Series C2 Financing Round
PR NEWSWIRE
21 Sep 2023
Share Share
Lynk hits main goal to wrap up clean sweep of phase 2 JAK trials

Lynk hits main goal to wrap up clean sweep of phase 2 JAK trials
Nick Paul Taylor FIERCE BIOTECH
23 Aug 2023
Share Share
Lynk Announced Positive Topline Data from Phase II Clinical Trial of LNK01001

Lynk Announced Positive Topline Data from Phase II Clinical Trial of LNK01001
PR NEWSWIRE
09 Aug 2023
Share Share
Lynk’s JAK1 inhibitor improves severity, itching in eczema study

Lynk’s JAK1 inhibitor improves severity, itching in eczema study
Gabrielle Masson FIERCE BIOTECH
09 Aug 2023
Share Share
Lynk Announces First Atopic Dermatitis Patient Dosed with LNK01004 in Ph Ib

Lynk Announces First Atopic Dermatitis Patient Dosed with LNK01004 in Ph Ib
PR NEWSWIRE
21 Jul 2023
Share Share
Lynk Pharmaceuticals Completes 200 Million RMB Series C1 Financing

Lynk Pharmaceuticals Completes 200 Million RMB Series C1 Financing
PR NEWSWIRE
31 May 2023
Share Share
Lynk doses first cohort in Phase Ib trial of psoriasis therapy

Lynk doses first cohort in Phase Ib trial of psoriasis therapy
CLINICAL TRIALS ARENA
25 May 2023
Share Share
Lynk Announces First Cohort of Psoriatic Patients Dosed with LNK01004

Lynk Announces First Cohort of Psoriatic Patients Dosed with LNK01004
PR NEWSWIRE
25 May 2023
Share Share
Lynk Announces Positive Results for LNK01003 in PI Trial in Healthy Subjects

Lynk Announces Positive Results for LNK01003 in PI Trial in Healthy Subjects
PR NEWSWIRE
04 Apr 2023
Share Share